| NTRA |
Natera, Inc. |
0 |
3.57% |
|
|
|
|
|
N/A |
0.00% |
53.42% |
16.02% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
2.94% |
|
|
|
|
|
N/A |
0.00% |
44.17% |
72.09% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
2.90% |
|
|
|
|
|
N/A |
0.00% |
35.09% |
56.98% |
|---|
| INCY |
Incyte Corporation |
0 |
2.90% |
|
|
|
|
|
N/A |
0.00% |
42.37% |
39.01% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
0 |
2.88% |
|
|
|
|
|
N/A |
0.00% |
34.71% |
23.57% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
2.69% |
|
|
|
|
|
N/A |
0.00% |
81.57% |
48.46% |
|---|
| INSM |
Insmed Incorporated |
0 |
2.60% |
|
|
|
|
|
N/A |
0.00% |
46.27% |
20.44% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
2.55% |
|
|
|
|
|
N/A |
0.00% |
29.88% |
28.22% |
|---|
| EXAS |
Exact Sciences Corporation |
0 |
2.45% |
|
|
|
|
|
N/A |
0.00% |
45.25% |
33.12% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
2.43% |
|
|
|
|
|
N/A |
0.00% |
41.52% |
13.06% |
|---|
| ABBV |
AbbVie Inc. |
0 |
2.34% |
|
|
|
|
|
N/A |
0.00% |
28.92% |
35.40% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
0 |
2.17% |
|
|
|
|
|
N/A |
0.00% |
61.15% |
27.72% |
|---|
| AMGN |
Amgen Inc. |
0 |
2.12% |
|
|
|
|
|
N/A |
0.00% |
33.11% |
38.93% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
2.04% |
|
|
|
|
|
N/A |
0.00% |
33.04% |
36.60% |
|---|
| BIIB |
Biogen Inc. |
0 |
2.03% |
|
|
|
|
|
N/A |
0.00% |
37.05% |
38.49% |
|---|
| VKTX |
Viking Therapeutics, Inc. |
0 |
1.87% |
|
|
|
|
|
N/A |
0.00% |
77.96% |
31.22% |
|---|
| TGTX |
TG Therapeutics, Inc. |
0 |
1.83% |
|
|
|
|
|
N/A |
0.00% |
56.82% |
38.31% |
|---|
| BPMC |
Blueprint Medicines Corporation |
0 |
1.74% |
|
|
|
|
|
N/A |
0.00% |
66.68% |
19.74% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
1.66% |
|
|
|
|
|
N/A |
0.00% |
39.66% |
53.19% |
|---|
| CYTK |
Cytokinetics, Incorporated |
0 |
1.64% |
|
|
|
|
|
N/A |
0.00% |
54.27% |
26.38% |
|---|
| MRNA |
Moderna, Inc. |
0 |
1.62% |
|
|
|
|
|
N/A |
0.00% |
74.20% |
44.74% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
1.48% |
|
|
|
|
|
N/A |
0.00% |
60.75% |
41.55% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
0 |
1.39% |
|
|
|
|
|
N/A |
0.00% |
37.56% |
28.31% |
|---|
| EXEL |
Exelixis, Inc. |
0 |
1.25% |
|
|
|
|
|
N/A |
0.00% |
35.76% |
33.72% |
|---|
| ROIV |
Roivant Sciences Ltd. |
0 |
1.24% |
|
|
|
|
|
N/A |
0.00% |
32.36% |
54.06% |
|---|
| ALKS |
Alkermes plc |
0 |
1.22% |
|
|
|
|
|
N/A |
0.00% |
55.46% |
49.24% |
|---|
| KRYS |
Krystal Biotech, Inc. |
0 |
1.20% |
|
|
|
|
|
N/A |
0.00% |
46.99% |
22.87% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
0 |
1.18% |
|
|
|
|
|
N/A |
0.00% |
57.02% |
24.72% |
|---|
| RVMD |
Revolution Medicines, Inc. |
0 |
1.17% |
|
|
|
|
|
N/A |
0.00% |
66.81% |
32.37% |
|---|
| ADMA |
ADMA Biologics, Inc. |
0 |
1.16% |
|
|
|
|
|
N/A |
0.00% |
61.47% |
9.90% |
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
0 |
1.07% |
|
|
|
|
|
N/A |
0.00% |
43.44% |
29.41% |
|---|
| BBIO |
BridgeBio Pharma, Inc. |
0 |
1.05% |
|
|
|
|
|
N/A |
0.00% |
60.00% |
4.42% |
|---|
| TWST |
Twist Bioscience Corporation |
0 |
1.05% |
|
|
|
|
|
N/A |
0.00% |
66.71% |
19.60% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
1.04% |
|
|
|
|
|
N/A |
0.00% |
67.15% |
60.52% |
|---|
| PCVX |
Vaxcyte, Inc. |
0 |
0.90% |
|
|
|
|
|
N/A |
0.00% |
62.20% |
40.61% |
|---|
| BHVN |
Biohaven Pharmaceutical Holding Company ... |
0 |
0.89% |
|
|
|
|
|
N/A |
0.00% |
62.50% |
52.61% |
|---|
| GERN |
Geron Corporation |
0 |
0.85% |
|
|
|
|
|
N/A |
0.00% |
92.88% |
17.40% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
0.84% |
|
|
|
|
|
N/A |
0.00% |
63.92% |
31.10% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
0.83% |
|
|
|
|
|
N/A |
0.00% |
70.01% |
3.40% |
|---|
| SWTX |
SpringWorks Therapeutics, Inc. |
0 |
0.82% |
|
|
|
|
|
N/A |
0.00% |
27.69% |
7.23% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
0 |
0.80% |
|
|
|
|
|
N/A |
0.00% |
233.30% |
71.87% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
0 |
0.78% |
|
|
|
|
|
N/A |
0.00% |
82.06% |
33.84% |
|---|
| SRRK |
Scholar Rock Holding Corporation |
0 |
0.77% |
|
|
|
|
|
N/A |
0.00% |
62.30% |
12.19% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
0.77% |
|
|
|
|
|
N/A |
0.00% |
52.38% |
39.63% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
0 |
0.77% |
|
|
|
|
|
N/A |
0.00% |
48.14% |
16.49% |
|---|
| ACLX |
Arcellx, Inc. |
0 |
0.73% |
|
|
|
|
|
N/A |
0.00% |
46.12% |
47.43% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
0.70% |
|
|
|
|
|
N/A |
0.00% |
71.90% |
39.52% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
0 |
0.67% |
|
|
|
|
|
N/A |
0.00% |
230.48% |
45.12% |
|---|
| IMVT |
Immunovant, Inc. |
0 |
0.66% |
|
|
|
|
|
N/A |
0.00% |
77.80% |
48.64% |
|---|
| JANX |
Janux Therapeutics, Inc. |
0 |
0.63% |
|
|
|
|
|
N/A |
0.00% |
81.13% |
19.22% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
0 |
0.63% |
|
|
|
|
|
N/A |
0.00% |
51.71% |
41.30% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
0.62% |
|
|
|
|
|
N/A |
0.00% |
56.04% |
34.65% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
0.61% |
|
|
|
|
|
N/A |
0.00% |
62.23% |
54.69% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
0 |
0.60% |
|
|
|
|
|
N/A |
0.00% |
67.83% |
37.26% |
|---|
| ARQT |
Arcutis Biotherapeutics, Inc. |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
80.40% |
32.49% |
|---|
| NUVL |
Nuvalent, Inc. |
0 |
0.58% |
|
|
|
|
|
N/A |
0.00% |
47.10% |
52.33% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
0.58% |
|
|
|
|
|
N/A |
0.00% |
68.70% |
7.40% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
49.91% |
41.83% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
0 |
0.56% |
|
|
|
|
|
N/A |
0.00% |
54.39% |
19.53% |
|---|
| NVAX |
Novavax, Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
85.64% |
26.87% |
|---|
| VERA |
Vera Therapeutics, Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
65.71% |
84.74% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
0.53% |
|
|
|
|
|
N/A |
0.00% |
84.48% |
58.07% |
|---|
| DVAX |
Dynavax Technologies Corporation |
0 |
0.53% |
|
|
|
|
|
N/A |
0.00% |
247.79% |
33.92% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
142.62% |
26.02% |
|---|
| ARDX |
Ardelyx, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
88.22% |
54.42% |
|---|
| VCEL |
Vericel Corporation |
0 |
0.47% |
|
|
|
|
|
N/A |
0.00% |
58.27% |
59.56% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
67.60% |
61.13% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
0 |
0.43% |
|
|
|
|
|
N/A |
0.00% |
50.70% |
16.09% |
|---|
| DNLI |
Denali Therapeutics Inc. |
0 |
0.43% |
|
|
|
|
|
N/A |
0.00% |
64.25% |
41.57% |
|---|
| SLNO |
Soleno Therapeutics, Inc. |
0 |
0.42% |
|
|
|
|
|
N/A |
0.00% |
69.57% |
16.02% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
42.34% |
22.16% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
73.43% |
23.37% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
66.75% |
93.90% |
|---|
| PRAX |
Praxis Precision Medicines, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
167.62% |
42.70% |
|---|
| IRON |
Disc Medicine, Inc. |
0 |
0.38% |
|
|
|
|
|
N/A |
0.00% |
76.09% |
38.78% |
|---|
| CLDX |
Celldex Therapeutics, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
48.11% |
20.10% |
|---|
| SNDX |
Syndax Pharmaceuticals, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
77.62% |
50.62% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
0 |
0.36% |
|
|
|
|
|
N/A |
0.00% |
102.73% |
13.13% |
|---|
| SMMT |
Summit Therapeutics Inc. |
0 |
0.32% |
|
|
|
|
|
N/A |
0.00% |
83.92% |
15.42% |
|---|
| MNKD |
MannKind Corporation |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
103.04% |
72.28% |
|---|
| VRDN |
Viridian Therapeutics, Inc. |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
48.83% |
30.64% |
|---|
| NRIX |
Nurix Therapeutics, Inc. |
0 |
0.30% |
|
|
|
|
|
N/A |
0.00% |
80.19% |
44.72% |
|---|
| DAWN |
Day One Biopharmaceuticals, Inc. |
0 |
0.27% |
|
|
|
|
|
N/A |
0.00% |
62.90% |
45.35% |
|---|
| SYRE |
Spyre Therapeutics, Inc. |
0 |
0.27% |
|
|
|
|
|
N/A |
0.00% |
139.55% |
29.04% |
|---|
| TVTX |
Travere Therapeutics, Inc. |
0 |
0.25% |
|
|
|
|
|
N/A |
0.00% |
77.53% |
1.72% |
|---|
| XNCR |
Xencor, Inc. |
0 |
0.25% |
|
|
|
|
|
N/A |
0.00% |
81.40% |
41.03% |
|---|
| CDNA |
CareDx, Inc |
0 |
0.24% |
|
|
|
|
|
N/A |
0.00% |
110.71% |
38.51% |
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
0.24% |
|
|
|
|
|
N/A |
0.00% |
60.35% |
64.76% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
0 |
0.24% |
|
|
|
|
|
N/A |
0.00% |
217.96% |
61.79% |
|---|
| CDMO |
AVID BIOSERVICES INC |
|
0.22% |
|
|
|
|
|
|
|
|
|
|---|
| ALT |
Altimmune, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
133.61% |
78.32% |
|---|
| IBRX |
ImmunityBio, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
162.94% |
58.25% |
|---|
| RCUS |
Arcus Biosciences, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
286.49% |
49.46% |
|---|
| IRWD |
Ironwood Pharmaceuticals, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
191.36% |
42.21% |
|---|
| CGEM |
Cullinan Oncology, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
173.08% |
76.26% |
|---|
| VIR |
Vir Biotechnology, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
70.90% |
60.16% |
|---|
| AVXL |
Anavex Life Sciences Corp. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
98.87% |
16.63% |
|---|
| EBS |
Emergent BioSolutions Inc. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
248.17% |
15.29% |
|---|
| REPL |
Replimune Group, Inc. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
122.01% |
26.39% |
|---|
| VERV |
Verve Therapeutics, Inc. |
0 |
0.18% |
|
|
|
|
|
N/A |
0.00% |
154.23% |
47.16% |
|---|